Skip to content

Primary Hyperlipidaemia

Primary hyperlipidaemia is a lipid disorder characterised by elevated low-density lipoprotein cholesterol, and its clinical importance lies in its association with the risk of cardiovascular disease.

Roszet

Rosuvastatin, Ezetimibe

40mg + 10mg

Rosuvastatin and ezetimibe tablets for high cholesterol and familial hypercholesterolaemia. One cuts cholesterol production, the other blocks absorption in the gut.

From$4.58/ tabletView

Key points

  • Primary hypercholesterolaemia exists in heterozygous-familial and non-familial forms, and may co-occur with mixed dyslipidaemia, managed alongside dietary modification.
  • Patients with type 1 diabetes, or newly diagnosed or poorly controlled type 2 diabetes, are considered highly likely to have co-morbid hypercholesterolaemia and mixed dyslipidaemia.

Medicines listed for Primary Hyperlipidaemia

The listed product for Primary Hyperlipidaemia is Roszet, a 40mg + 10mg tablet combining Rosuvastatin and Ezetimibe. Rosuvastatin is a statin that reduces cholesterol production in the liver, while ezetimibe limits cholesterol absorption from the gut.

Further reading